XML 131 R106.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Information (Segment Profit by Reportable Segment) (Details)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2024
USD ($)
segment
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                  
Operating earnings/(loss) $ 369 $ 505 $ (32) $ 604 $ (86) $ 123 $ 1,243 $ 752 $ (607)
Number of Reportable Segments | segment             2    
Operating Segments                  
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                  
Operating earnings/(loss)             $ 2,530 2,130 1,969
Operating Segments | Pharmaceutical and Specialty Solutions                  
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                  
Operating earnings/(loss)             2,015 1,881 1,643
Operating Segments | GMPD                  
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                  
Operating earnings/(loss)             92 (147) (64)
Operating Segments | Other Operating Segment                  
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                  
Operating earnings/(loss)             423 396 390
Total operating earnings/(loss)                  
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                  
Operating earnings/(loss)             $ (1,287) $ (1,378) $ (2,576)